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To determine the changes in thyroid function tests in children who underwent 
antiepileptic therapy in Shahid Beheshti Hospital, Kashan, in 2008.
Materials & Methods 
This analytical-observational study was carried out in a cohort fashion without 
an external control group (self controlled) on 45 children with new onset epilepsy 
who had not been previously treated with antiepileptic medications. Three 
subjects were excluded from the study because of presenting clinical symptoms 
of hypothyroidism. Plasma levels of TSH, T3, FT3, T4 and FT4 hormones were 
measured and compared at baseline and 3 and 6 months after treatment.
Results
The results of Mann-Whitney statistical analysis suggested that the increase in 
the plasma level of TSH was significant only in the Sodium Valproate group. 
The plasma level of T3 significantly decreased 3 and 6 months after treatment in 
the Phenobarbital group while the plasma level of FT3 significantly decreased 
only in the Sodium Valproate group. The decrease in T4 plasma level was 
significant in all groups (Carbamazepine group, Sodium Valproate group 
and Phenobarbital group) 3 and 6 months after the onset of treatment but the 
decreasing in FT4 plasma level was only significant in the Carbamazepine 
group 6 months after the commencement of treatment.
Conclusion
Phenobarbital had the least effect on thyroid hormones. Considering the effect 
of such medications on thyroid function tests, it seems necessary to check the 
plasma levels of hormones periodically after beginning the treatment.
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Introduction
Seizure is a sudden change in motor and/or behavioral activity with a limited duration 
due to abnormal electrical functions in the brain. Seizure is a common disorder in 
childhood as it occurs in 10% of them. Less than one third of seizures that occur 
in children are due to epilepsy in which the seizures are motivated from inside the 
brain repeatedly. Epidemiologically, epilepsy is defined as a condition in which 2 or 
more un-motivated seizures occur with an interval of more than 24 hours (1).
Treatment with antiepileptic agents has a lot of complications such as affecting the 
function of endocrine glands (e.g. thyroid) and bone marrow healthiness (2).
Many drugs can change plasma levels of T3 and T4. Among these medications, 
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antiepileptic agents such as Phenobarbital, Phenytoin, 
Carbamazepine and Sodium Valproate are of importance 
since if their changes are not identified, they can lead to 
misinterpretation of thyroid function tests. These drugs 
are powerful inducers of liver microsomal enzymes 
which can result in changing the metabolism of thyroid 
hormones (2).
In various studies, different results have been achieved 
regarding the effect(s) of antiepileptic medications on 
thyroid function tests (3-5).Thus, considering the high 
incidence of seizure in the first years of life and the high 
usage of antiepileptic agents and also the fact that thyroid 
gland dysfunction in neonates and children can lead to 
growth and developmental retardation (1), the current 
study was designed to evaluate thyroid function tests in 
children who use antiepileptic medications in an attempt 
to adentify the drug with the fewest complications.
Materials & Methods 
This analytical-observational study was carried out in 
a cohort fashion without an external control group (self 
controlled) on 47 children with epilepsy who were referred 
to the pediatric ward of Shahid Beheshti Hospital, Kashan. 
They had not received any antiepileptic medications 
prior to the study. After explaining the stages of the study 
to the parents, every child who was hospitalized in the 
pediatric ward with the diagnosis of epilepsy (2 or more 
un-motivated seizures with an interval of more than 24 
hours) was included in the study. Patients with disturbed 
thyroid function tests in this stage (before study) were 
excluded the study (2 subjects) and three subjects were 
excluded from the study because of developing symptoms 
of hypothyroidism such as constipation, lethargy, loss of 
appetite and low activity and were therefore referred to 
an endocrinologist. So, the study was carried out with 
42 subjects (all analyses were done on this sample size). 
Inclusion criteria included new cases of epilepsy, no 
history of using antiepileptic medications or any other 
drug that may affect thyroid gland function and no 
history of endocrine, cardiovascular, neurometabolic or 
other chronic diseases.
Before starting the treatment with antiepileptic agents, a 
5 CC heparinated blood sample was taken by a pediatric 
ward nurse and sent to laboratory in order for thyroid 
function tests, including TSH, T3, FT3, T4 and FT4, to 
be evaluated. All laboratory evaluations were handled 
by a technician who was blinded to the study through 
RadioImmunoAssay (RIA). The normal range of T3, 
T4 and TSH plasma levels were 1.19-1.7ng/ml, 5.5-
13µg/dl and less than 5µU/ml, respectively. Tests results 
of each patient were recorded in an information sheet. 
After the patients passed the acute phase of seizure, they 
underwent treatment with antiepileptic agents including 
Carbamazepine 20mg/kg, Phenobarbital 5mg/kg and 
Sodium Valproate 25mg/kg (1). Choosing the medicine 
was with regard to the seizure type. Three and six months 
after treatment with antiepileptics, thyroid function tests 
were re-evaluated in the same laboratory and their results 
were recorded in the information sheets. All subjects were 
asked if they used other medications that could affect 
thyroid function tests or if they developed endocrine or 
other diseases during the study. It should be mentioned 
that 2 patients who were receiving Sodium Valproate 
and one patient who was treated with Carbamazepine 
were excluded from the study because of developing 
symptoms at the end of the third month and were then 
referred to an endocrinologist. Patients’ information was 
collected using a holistic questionnaire that was prepared 
based on the variables of the study. Relevant information 
was extracted from the information sheets and data 
analysis was performed via appropriate abundance 
tables based on study variables. Data was analyzed with 
Repeated Measurement statistical test (Friedman model) 
using SPSS#13 software in order to compare the tests 
results. A statistical lower limit of 0.05 was considered 
for significance in Friedman test. Significant results were 
processed with Mann Whitney test with a significance 
level of 0.017 because of making comparisons for three 
times. Comparisons were made between plasma levels 
of hormones at baseline and after 3 and 6 months and 
also between plasma levels of hormones after 3 months 
and after 6 months (Tables 1, 2).
Results
Fifteen subjects received Carbamazepine therapy, 15 
subjects were treated with Sodium Valproate and 12 
subjects underwent Phenobarbital therapy. Mean age of 
the subjects was 7.62 years (minimum 4 and maximum 
13 years old).
The decrease in the plasma level of FT3 was only 
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significant in the Sodium Valproate group. T4 plasma 
level decreased significantly in all 3 groups of 
Carbamazepine, Sodium Valproate and Phenobarbital 
3 and 6 months after treatment while FT4 plasma level 
decreased significantly only in the Carbamazepine group 
6 months after treatment. Table 1 shows mean plasma 
levels of thyroid hormones at baseline and 3 and 6 
months after treatment. The results of Mann Whitney 
test showed that the increase in the plasma level of TSH 
was only significant in the Sodium Valproate group. Only 
subjects in the Phenobarbital group showed a significant 
decrease in T3 plasma level 3 and 6 months after the 
onset of treatment. 
Discussion
As mentioned, various differences in thyroid function 
tests were seen in patients who received antiepileptic 
medications. Other studies have reached similar 
conclusions as Cansu et al. (2006) evaluated 55 children 
with epilepsy who were treated with Sodium Valproate 
and Carbamazepine in Turkey. He suggested that in 
patients on Carbamazepine treatment, plasma levels of 
FT4, T4, FT3, and T3 decreased significantly (P<0.05). 
Also, in children receiving Sodium Valproate, plasma 
levels of FT4, T4, FT3, and T3 were within normal 
range and the same as baseline but TSH plasma level 
increased significantly 6 months after treatment (P<0.05). 
Subclinical hypothyroidism was seen in patients treated 
with Sodium Valproate (5).
In the current study, only patients treated with Sodium 
Valproate experienced a significant increase in the plasma 
level of TSH. However, patients who were treated with 
Carbamazepine showed an increase in the plasma level 
of FT3 and a decrease in the plasma levels of  T4 and 
FT4.
Vainionpaa et al. (2004) compared plasma levels of 
thyroid hormone between 41 children treated with 
Carbamazepine and 19 children treated with Sodium 
Valproate, with 54 healthy volunteers as the control 
group in Finland. Children treated with Carbamazepine 
showed a significant decrease in plasma level of T3 and 
T4 but the level of TSH was normal. Children treated 
with Sodium Valproate showed an increase in TSH level 
but the plasma levels of T3 and T4 were normal (6).
Hegedus et al. (1989) compared 28 patients who were 
treated with Carbamazepine and volunteers in the 
control group in Spain. Mean plasma level of T3 and T4 
decreased in patients (7).
In the mentioned studies as well as the current study, 
a significant decrease in T4 plasma level was seen in 
children treated with Carbamazepine but no significant 
change in T3 plasma level was seen in them.
Mikati et al. compared thyroid gland function between 
143 children treated with Sodium Valproate and 35 
children as a control group. Subclinical hypothyroidism 
was recorded in 25.2% of the patients; however, none 
of children in the control group developed subclinical 
hypothyroidism (P<0.001) (8).
In the current study, subclinical hypothyroidism was also 
recorded in children treated with Sodium Valproate.
Hirfanoglu et al. (2007) evaluated thyroid gland function 
between 12 children treated with Carbamazepine 
and 31 children treated with Sodium Valproate in 
Turkey. T4 mean plasma level in patients treated with 
Carbamazepine was significantly lower than the group 
treated with Sodium Valproate (P<0.016). TSH showed 
no significant difference in either group (9).
Tanaka et al. evaluated 287 children who received 
antiepileptic medication (26 children treated with 
Carbamazepine, 63 children treated with Phenobarbital, 
66 children treated with Sodium Valproate and 132 
children treated with several medications). A Decrease 
in the mean plasma level of T4 and T3 was recorded in 
patients treated with Carbamazepine and Phenobarbital 
but not in patients treated with Sodium Valproate (10).
Similar to the above-mentioned study, in the current 
study, a decrease in T3 plasma level was seen in patients 
treated with Phenobarbital as well as a significant 
decrease in plasma level of T4 in patients treated with 
Carbamazepine and Phenobarbital.
Regarding the effects of antiepileptics on central 
nervous system, some studies have examined the 
hypothesis that antiepileptic agents can decrease plasma 
levels of hormones, because of their central effects on 
hypothalamus-pituitary-thyroid axis. Except for some 
limited studies (5-12) that showed a decrease in the 
plasma levels of hormones due to the central disturbance 
induced by such medications, the majority of them (13-
14) did not suggest any problems in the hypothalamus-
pituitary-thyroid axis.
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Another hypothesis is that Carbamazepine increases the 
metabolism of thyroid hormones through activating the 
P450 enzymatic system in the liver (6).
As seen previously, there are a variety of changes 
in thyroid function tests in patients who receive 
antiepileptic medications and most of them are related to 
Sodium Valproate. Phenobarbital and Carbamazepine, as 
mentioned earlier, have fewer effects on thyroid function 
tests. In our patients who were treated with Sodium 
Valproate, a significant increase in TSH level and a 
decrease in T4 and FT3 were obvious and in patients 
treated with Carbamazepine, a significant decrease in T4 
and FT4 were seen. In patients treated with Phenobarbital, 
T3 and T4 significantly decreased. Unlike many other 
studies, we also investigated the effect of Phenobarbital 
on thyroid hormones in epileptic children.
In the end, we suggest that TFT (Thyroid Function Tests) 
be evaluated in the children who receive antiepileptic 
therapy.
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Before treatment 2.75±1.35 3.74±1.35 3.22±1.40
3 months after 2.75±1.35 4.85±1.68 3.25±1.41
6 months after 2.77±1.35 4.48±1.67 3.41±1.36
P-value 0.368  0.0001 0.044
T3
Before treatment 139.28±22.60 143.87±27.48 153.66±21.64
3 months after 140.07±22.88 162.81±83.77 152.25±21.59
6 months after 140.07±22.88 162.81±83.77 152.25±21.59
P-value 0.276 0.069 0.001
FT3
Before treatment 354.14±125.20 372±138.61 429.16±150.78
3 months after 355.92±126.02 370.37±138.88 428.33±150.76
6 months after 355.92±126.02 370.37±138.88 428.33±150.76
P-value 0.001 0.0001 0.165
T4
Before treatment 9.05±1.55 8.49±1.84 8.02±1.58
3 months after 5.87±0.87 8.25±1.64 7.86±1.59
6 months after 5.52±0.8 8.25±1.64 7.86±1.59
P-value <0.0001 <0.0001 <0.0001
FT4
Before treatment 1.62±0.21 1.56±0.32 1.48±0.32
3 months after 1.57±0.26 1.46±0.32 1.44±0.28
6 months after 1.54±0.25 1.46±0.32 1.44±0.28
P-value 0.004 0.007 0.018
(P-value<0.05 is significant)
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Carbamazepine Sodium Valproate Phenobarbital
TSH
Baseline and 3 months 1 0.003 0.473
Baseline and 6 months 0.194 0.003 0.101
3 months and 6 months 0.194 0.317 0.068
T3
Baseline and 3 months 0.121 0.141 0.016
Baseline and 6 months 0.121 0.141 0.016
3 months and 6 months 1 1 1
FT3
Baseline and 3 months 0.018 0.007 0.078
Baseline and 6 months 0.018 0.007 0.078
3 months and 6 months 1 1 1
T4
Baseline and 3 months 0.001 0.011 0.011
Baseline and 6 months 0.001 0.011 0.011
3 months and 6 months 0.043 1 1
FT4
Baseline and 3 months 0.039 0.039 0.059
Baseline and 6 months 0.016 0.039 0.059
3 months and 6 months 0.102 1 1
(P-value<0.017 is significant)
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